RANK is essential for osteoclast and lymph node development

Genes and Development

Volumn 13, Issue 18, 1999, Pages 2412-2424

  Dougall, William C ^b   Glaccum, Moira ^b   Charrier, Keith ^b   Rohrbach, Kathy ^b   Brasel, Kenneth ^b   De Smedt, Thibaut ^b   Daro, Elizabeth ^b   Smith, Jeffery ^b   Tometsko, Mark E ^b   Maliszewski, Charles R ^b   Armstrong, Allison ^b   Shen, Victor ^a   Bain, Steven ^a   Cosman, David ^b   Anderson, Dirk ^b   Morrissey, Philip J ^b   Peschon, Jacques J ^b   Schuh, JoAnn ^b  

^a AMGEN INC   (United States)

^b Skeletech Inc   (United States)

Author keywords

Knockout mice; Lymph node; Osteoclast; Osteopetrosis; RANK RANKL; TNF receptor

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; LYMPH NODE; MACROPHAGE; MALE; MOUSE; NONHUMAN; ORGANOGENESIS; OSTEOCLAST; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; STEM CELL;

ANIMALS; B-LYMPHOCYTES; BONE AND BONES; BONE RESORPTION; CARRIER PROTEINS; DENDRITIC CELLS; FLOW CYTOMETRY; GENE TARGETING; HEMATOPOIESIS, EXTRAMEDULLARY; HEMATOPOIETIC STEM CELLS; LYMPH NODES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPETROSIS; PEYER'S PATCHES; PHENOTYPE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN;

EID: 0033568341     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.18.2412     Document Type: Article

References (58)

1. Anderson, D.M., E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, E.R. Roux, M.C. Teepe, R.F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
2. Bachmann, M.F., B.R. Wong, R. Josien, R.M. Steinman, A. Oxenius, and Y. Choi. 1999. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189: 1025-1031.
3. Begg, S.K., J.M. Radley, J.W. Pollard, O.T. Chisholm, E.R. Stanley, and I. Bertoncello. 1993. Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177: 237-242.
4. Brasel, K., H.J. McKenna, P.J. Morrissey, K. Charrier, A.E. Morris, C.C. Lee, D.E. Williams, and S.D. Lyman. 1996. Hematologic effects of flt3 ligand in vivo in mice. Blood 88: 2004-2012.
5. Bucay, N., I. Sarosi, C.R. Dunstan, S. Moroney, J. Tarpley, C. Capparelli, S. Scully, H.L. Tan, W. Xu, D.L. Lacey, W.J. Boyle, and W.S. Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Dev. 12: 1260-1268.
6. Chaplin, D.D. and Y. Fu. 1998. Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10: 289-297.
7. Darnay, B.G., V. Haridas, J. Ni, P.A. Moore, and B.B. Aggarwal. 1998. Characterization of the intracellular domain of Receptor Activator of NF-KB (RANK). J. Biol. Chem. 273: 20551-20555.
8. Darnay, B.G., J. Ni, P.A. Moore, and B.B. Aggarwal. 1999. Activation of NF-KB by RANK requires Tumor Necrosis Factor-Associated Factor (TRAF] 6 and NF-KB-inducing kinase. J. Biol. Chem. 274: 7724-7731.
9. De Smedt, T., B. Pajak, G.G. Klaus, R.J. Noelle, J. Urbain, O. Leo, and M. Moser. 1998. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J. Immunol. 161: 4476-4479.
10. Emery, J.G., P. McDonnell, M. Brigham Burke, K.C. Deen, S. Lyn, C. Silverman, E. Dul, E.R. Appelbaum, C. Eichman, R. DiPrinzo et al. 1998. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273: 14363-14367.
11. Erlebacher, A., E.H. Filvaroff, S.E. Gitelman, and R. Derynck. 1995. Toward a molecular understanding of skeletal development. Cell 80: 371-378.
12. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E.W. Shores, K.D. Brown, A. Leonardi, T. Tran, B.F. Boyce, and U. Siebenlist. 1997. Requirement for NF-KB in osteoclast and B-cell development. Genes & Dev. 11: 3482-3496.
13. Futterer, A., K. Mink, A. Luz, M.H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9: 59-70.
14. Galibert, L., M.E. Tometsko, D.M. Anderson, D. Cosman, and W.C. Dougall. 1998. The involvement of multiple Tumor Necrosis Factor Receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-KB, a member of the TNFR superfamily. J. Biol. Chem. 273: 34120-34127.
15. Godfrey, D.I. and A. Zlotnik. 1993. Control points in early T-cell development. Immunol. Today 14: 547-553.
16. Green, E.A. and R.A. Flavell. 1999. TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation. J. Exp. Med. 189: 1017-1020.
17. Grigoriadis, A.E., Z.-Q. Wang, M.G. Cecchini, W. Hofstetter, R. Felix, H.A. Fleisch, and E.F. Wagner. 1994. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448.
18. Guise, T.A. and G.R. Mundy. 1998. Cancer and bone. Endocr. Rev. 19: 18-54.
19. Hestdal, K., F.W. Ruscetti, J.N. Ihle, S.E.W. Jacobsen, C.M. Dubois, W.C. Kopp, D.L. Longo, and J.R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression of murine bone marrow cells. J. Immunol. 147: 22-28.
20. Hofbauer, L.C., C.R. Dunstan, T.C. Spelsberg, B.L. Riggs, and S. Khosla. 1998. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem. Biophys. Res. Commun. 250: 776-781.
21. Hsu, H., D.L. Lacey, C.R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H.L. Tan, G. Elliott, M.J. Kelley, I. Sarosi et al. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. 96: 3540-3545.
22. Iotsova, V., J. Caamano, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-KB1 and NF-KB2. Nat. Med. 3: 1285-1289.
23. Jimi, E., S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi, and T. Suda. 1999. Osteoclast Differentiation Factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163: 434-442.
24. Johnson, R.S., B.M. Spiegelman, and V. Papaioannou. 1992. Pleiotropic effects of a null mutation in the c-fos proto-on-cogene. Cell 71: 577-586.
25. Josien, R., B.R. Wong, H. Li, R.M. Steinman, and Y. Choi. 1999. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 162: 2562-2568.
26. Karsenty, G. 1998. Genetics of skeletogenesis. Dev. Genet. 22: : 301-313.
27. Kong, Y.Y., H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, C. Capparelli, S. Morony, A. Oliveira-dos-Santos, G. Van, A. Itie et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
28. Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
29. Liu, C., R. Sanghvi, J.M. Burnell, and G.A. Howard. 1987. Simultaneous demonstration of bone alkaline and acid phosphatase activities in plastic-embedded sections and differential inhibition of the activities. Histochemistry 86: 559-565.
30. Lomaga, M.A., W.-C. Yeh, I. Sarosi, G.S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40 and LPS signaling. Genes & Dev. 13: 1015-1024.
31. Lowell, C.A., M. Niwa, P. Soriano, and H.E. Varmus. 1996. Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis. Blood 87: 1780-1792.
32. Maraskovsky, E., K. Brasel, M. Teepe, E.R. Roux, S.D. Lyman, K. Shortman, and H.J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962.
33. Milhaud, G., M.L. Labat, and Y. Moricard. 1983. Dichloromethylene-diphosphate induced impairment of T-lymphocyte function. Proc. Natl. Acad. Sci. 80: 4469-4473.
34. Nakagawa, N., M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, K. Yano, T. Morinaga, and K. Higashio. 1998. RANK is the essential signaling receptor for osteoclast differntiation factor in osteoclastogenesis. Biochem. Biophy. Res. Commun. 253: 395-400.
35. Okada, S., Z.-Q. Wang, A.E. Grigoriadis, E.F. Wagner, and T. von Ruden. 1994. Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol. Cell. Biol. 14: 382-390.
36. Pulendran, B., J. Lingappa, M.K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C.R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo. J. Immunol. 159: 2222-2231.
37. Roodman, G.D. 1996. Advances in bone biology: The osteoclast. Endoc. Rev. 17: 308-332.
38. Saftig, P., E. Hunziker, O. Wehmeyer, S. Jones, A. Boyde, W. Rommerskirch, J. Detlev Moritz, P. Schu, and K. von Figura. 1998. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. 95: 13453-13458.
39. Simonet, W.S., D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Luthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone et al. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
40. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76: 959-960.
41. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
42. Stuber, E., M. Neurath, D. Calderhead, H.P. Fell, and W. Strober. 1995. Crosslinking of OX40 ligand, a member of the TNF/ NGF cytokine family, induces proliferation and differentiation of murine splenic B cells. Immunity 2: 507-521.
43. Suda, T., N. Takahashi, and T.J. Martin. 1992. Modulation of osteoclast differentiation. Endocr. Rev. 13: 66-80.
44. Takai, H., M. Kanematsu, K. Yano, E. Tsuda, K. Higashio, K. Ikeda, K. Watanabe, and Y. Yamada. 1998. Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J. Biol. Chem. 273: 27091-27096.
45. Tondravi, M.M., S.R. McKercher, K. Anderson, J.M. Erdmann, M. Quiroz, R. Maki, and S.L. Teitelbaum. 1997. Osteopetrosis in mice lacking haematopoietic transcription factor PU. 1. Nature 386: 81-84.
46. Tsukii, K., N. Shima, S. Mochizuki, K. Yamaguchi, M. Kinosaki, K. Yano, O. Shibata, N. Udagawa, H. Yasuda, T. Suda, and K. Higashio. 1998. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem. Biophys. Res. Commun. 246: 337-341.
47. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand transduced co-stimulation of T cells in the development of helper function. Nature 378: 620-623.
48. van Kooten, C. and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9: 330-337.
49. Wiley, S.R., E.G. Goodwin, and C.A. Smith. 1996. Reverse signaling via CD30 ligand. J. Immunol. 157: 3635-3639.
50. Wong, B.R., R. Josien, S.Y. Lee, B. Sauter, H.L. Li, R.M. Steinman, and Y. Choi. 1997a. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186: 2075-2080.
51. Wong, B.R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F.S. Bartlett, W.N. Frankel, S.Y. Lee, and Y. Choi. 1997b. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272: 25190-25194.
52. Wong, B.R., R. Josien, S.Y. Lee, M. Vologodskaia, R.M. Steinman, and Y. Choi. 1998. The TRAF family of signal transducers mediates NF-KB activation by the TRANCE receptor. J. Biol. Chem. 273: 28355-28359.
53. Xu, Y., G. Cheng, and D. Baltimore. 1996. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5: 407-415.
54. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami et al. 1998a. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. 95: 3597-3602.
55. Yasuda, H., N. Shima, N. Nakagawa, S. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama et al. 1998b. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 1329-1337.
56. Yeh, W.C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J.L. de la Pompa, D. Ferrick, B. Hum, N. Iscove et al. 1997. Early lethality, functional NF-KB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725.
57. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L.D. Shultz, and S. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage-colony stimulating factor gene. Nature 345: 442-444.
58. Yun, T.J., P.M. Chaudhary, G.L. Shu, J.K. Frazer, M.K. Ewings, S.M. Schwartz, V. Pascual, L.E. Hood, and E.A. Clark. 1998. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J. Immunol. 161: 6113-6121.